Medical Marijuana Stocks and Legalization Movement Get Support From CNN's Dr. Sanjay Gupta

NEW YORK, NY--(Marketwired - Aug 9, 2013) - Everyone is entitled to change their mind, and even doctors who hold strong opinions are allowed a mulligan every now and then. CNN's chief medical correspondent Dr. Sanjay Gupta is taking his "do-over" public in a new documentary titled Weed. Gupta has just reversed his position on medical marijuana, and in doing so, he gives companies engaged in medical marijuana research like Nuvilex, Inc. (OTCQB: NVLX) and pro-cannabis groups in states all over the country a legitimate voice on their side.

Dr. Gupta's documentary, Weed, will air on Sunday, August 11 at 8 p.m. ET on CNN, and it takes a long look into the use of marijuana for medicinal purposes by digging into its risk for abuse, medical benefits and even tackles the challenges of marijuana research like Nuvilex's subsidiary, Medical Marijuana Sciences, Inc., has planned for the use of cannabis to treat cancers of the brain. 

In a piece Gupta wrote for CNN to discuss the film, he went as far as to apologize for his previous stance. "I apologize because I didn't look hard enough, until now. I didn't look far enough. I didn't review papers from smaller labs in other countries doing some remarkable research, and I was too dismissive of the loud chorus of legitimate patients whose symptoms improved on cannabis."

With states all over the U.S. legalizing marijuana for medicinal purposes, more and more eyes are opening to the movement. Even Sanjay Gupta has come a long way from his 2009 Time magazine article "Why I Would Vote No on Pot." "We have been terribly and systematically misled for nearly 70 years in the United States, and I apologize for my own role in that," said Sanjay Gupta.

Gupta's film should be eye opening to investors of marijuana stocks and to those fighting for legalization. With his dramatic shift, his film could very well help sway others in the debate. 

About Stock Market Media Group
Stock Market Media Group is a full service Investment Relations firm specializing in Research and Content Development. It offers a platform for CEOs to tell their story through the media with Research Reports, CEO Interviews and Feature Articles while building a library of Research for Investors. For more information: www.stockmarketmediagroup.com